The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study

Evangelista, Karine Cavalcanti Maurício SenaPedrosa, Lucia Fatima CamposPaiva, Maria Sanali Moura OliveiraDias, Paula Cristina SilveiraFerreira, Diana Quitéria CabralCozzolino, Sílvia Maria FranciscatoFaulin, Tanize Espírito SantoAbdalla, Dulcinéia Saes Parra2024-08-262024-08-262015-03EVANGELISTA, Karine Cavalcanti Maurício Sena; PEDROSA, Lucia Fatima Campos; PAIVA, Maria Sanali Moura Oliveira; DIAS, Paula Cristina Silveira; FERREIRA, Diana Quitéria Cabral; COZZOLINO, Sílvia Maria Franciscato; FAULIN, Tanize Espírito Santo; ABDALLA, Dulcinéia Saes Parra. The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study. Plos One, [S.l.], v. 10, n. 3, p. 1-14, 18 mar. 2015. DOI: 10.1371/journal.pone.0119830. Disponível em: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0119830. Acesso em: 26 jul. 2024.https://repositorio.ufrn.br/handle/123456789/59890Attribution 3.0 Brazilhttp://creativecommons.org/licenses/by/3.0/br/Rosuvastatin therapyZinc and selenium supplementationCoronary artery diseaseLipid profileAntioxidant enzymesThe hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled studyarticlehttp://dx.doi.org/10.1371/journal.pone.0119830